1.3 Chapter-Specific and Setting-Specific Coding Guidelines
Key Takeaways
Sections II and III address non-outpatient reporting, but their uncertain-diagnosis provisions have the narrower hospital-inpatient scope stated in II.H and III.C.
Outpatient uncertainty is addressed in IV.H; report the highest degree of certainty rather than assigning a suspected disease as established.
Urosepsis has no default Index code and requires provider clarification; sepsis sequencing depends on timing and applicable chapter-specific instructions.
Neoplasm sequencing depends on the treatment purpose and documented complication, with distinct rules for malignancy-associated anemia, therapy-associated anemia, and dehydration.
Respiratory-failure sequencing depends on admission circumstances; adverse effects, poisonings, underdosing, and toxic effects follow different drug-event coding pathways.
Start with the encounter setting and the reason for care
The same clinical wording can produce different coding decisions in different settings. The CDI reviewer must establish which reporting rules apply before deciding whether a diagnosis can be assigned or sequenced first. Chapter-specific instructions then address conditions such as sepsis, neoplasms, diabetes, and drug-related events.
The FY2027 ICD-10-CM Official Guidelines organize this work into four sections:
| Section | Main subject | Applicability distinction |
|---|---|---|
| I | Conventions, general guidelines, and chapter-specific guidelines | Apply across settings unless otherwise indicated |
| II | Principal diagnosis selection | Non-outpatient settings; read the scope of each provision |
| III | Additional diagnoses | Non-outpatient reporting; conditions must meet applicable reporting requirements |
| IV | Outpatient diagnosis reporting | Includes hospital outpatient services and provider-based office visits |
Sections II and III are not restricted as a whole to acute hospital admissions. Their discussions describe the expanded use of UHDDS definitions in non-outpatient settings. However, the uncertain-diagnosis provisions within those sections have a narrower stated scope. Do not transfer one provision's limitation to an entire section or assume that every non-outpatient service uses the hospital uncertainty rule.
Uncertain diagnoses: timing, setting, and exceptions
Sections II.H and III.C permit coding qualifying uncertain diagnoses documented at discharge as if established for inpatient admissions to short-term, acute, long-term care, and psychiatric hospitals. The documentation may use terms such as probable, suspected, likely, or possible. Review the final diagnostic conclusions and applicable chapter-specific exceptions; an early differential that was subsequently ruled out does not satisfy this rule.
For example, an acute inpatient discharge summary may retain probable aspiration pneumonia after evaluation and treatment. The absence of a microbiologic confirmation does not by itself require replacing that final uncertain diagnosis with symptoms. In contrast, an admission note saying rule out pneumonia followed by a final conclusion that pneumonia was excluded does not support coding pneumonia as established.
Section IV.H directs outpatient reporting to the highest degree of certainty for the encounter, such as a confirmed condition, symptom, sign, abnormal finding, or other reason for the visit. Do not assign a suspected disease as established by importing the hospital inpatient rule. Observation is an outpatient service, even when the patient remains overnight in a hospital bed.
This distinction addresses diagnosis assignment, not an automatic severity or payment result. A reportable uncertain inpatient diagnosis still needs the correct complete code and sequence. Its effect on an MS-DRG depends on the versioned grouping rules and full claim.
Sepsis: distinguish documentation from sequence
Under Section I.C.1.d, assign the appropriate systemic-infection code for documented sepsis. If the infection or causal organism is not further specified, the guideline directs A41.9, sepsis, unspecified organism. A positive culture is not itself the provider's diagnosis of sepsis.
Urosepsis has no default code in the Alphabetic Index. It is not synonymous with sepsis and does not default to urinary tract infection. Query the provider for clarification when this term is used; the resulting documentation determines the supported assignment.
For severe sepsis, code the underlying systemic infection, the appropriate complete code from R65.2-, and the associated acute organ dysfunctions. The minimum-two-code statement does not eliminate the requirement to report associated organ dysfunction. When the relationship between sepsis and an acute organ dysfunction is unclear, query rather than infer the relationship from coexistence.
Sequencing requires the admission circumstances and applicable instructions:
- If severe sepsis is present on admission and meets the principal-diagnosis definition, sequence the underlying systemic infection as principal, with the required severe-sepsis and organ-dysfunction codes.
- If admission is for a localized infection and sepsis develops afterward, the localized infection remains first under the applicable guideline.
- Postprocedural and obstetric infections have specific sequencing instructions. Postprocedural septic shock follows its own pathway; R65.21, severe sepsis with septic shock, is not assigned for postprocedural septic shock.
- Other specific situations, including infection-associated hemolytic-uremic syndrome, can direct a different principal diagnosis.
Thus, a septic-shock or severe-sepsis code cannot be principal, but that does not establish that a systemic-infection code must be principal in every case. Never use a generic three-line sequence as a substitute for the scenario's timing and chapter-specific rules.
Neoplasms: identify what the admission treats
Section I.C.2 distinguishes treatment of a malignancy, treatment of a secondary site, administration of therapy, and management of complications. The presence of cancer does not establish a universal principal diagnosis.
| Stated circumstances | Guideline direction |
|---|---|
| Malignancy chiefly responsible for admission, treatment directed at primary site | Primary malignancy is principal, subject to the specified therapy exception |
| Treatment directed solely at a secondary malignant site | Secondary malignancy is principal even if the primary remains present |
| Encounter chiefly for antineoplastic chemotherapy, immunotherapy, or external beam radiation | Appropriate encounter code, Z51.11, Z51.12, or Z51.0, is principal/first-listed, with the treated malignancy additional |
| Admission for insertion or implantation of radioactive elements, such as brachytherapy | Malignancy is principal/first-listed; do not assign Z51.0 for this circumstance |
| Management of anemia associated with malignancy, with only anemia treated | Malignancy first, followed by the appropriate anemia code, such as D63.0 |
| Management of anemia due to an adverse effect of chemotherapy or immunotherapy, with only anemia treated | Anemia first, followed by the appropriate neoplasm and adverse-effect codes |
| Management of dehydration due to malignancy, with only dehydration treated | Dehydration first, followed by the malignancy |
The contrast between malignancy-associated anemia and therapy-associated anemia is an important exam reasoning task. Establish the documented relationship and treatment purpose rather than selecting the condition that appears most severe. An encounter involving tumor removal followed by adjunct therapy also differs from an encounter chiefly for administering therapy; consult the specific provision.
Diabetes and hypertensive combinations
Section I.C.4.a classifies diabetes by type and documented cause. If type is not documented, the default is E11.-, type 2 diabetes. Do not use insulin treatment alone to infer type 1 diabetes, or disregard an established drug-induced or other secondary form. Verify the actual Index relationship before applying the with convention to a complication.
For type 2 diabetes routinely treated with insulin, Z79.4, long term (current) use of insulin, identifies that long-term use. Temporary insulin to control blood glucose during an encounter does not establish long-term use. Missing type, complication specificity, and medication status are separate review questions.
Section I.C.9.a provides hypertension combination rules. Hypertension with specified heart disease and hypertension with chronic kidney disease have presumed relationships unless the documentation clearly states they are unrelated. Use the appropriate combination code and required additional codes. If both hypertensive heart disease and CKD are present, examine I13.- rather than separately assigning I11.- and I12.-.
For hypertension with stage 3b CKD, no heart disease, and no contrary documentation, I12.9 with N18.32 captures hypertensive CKD and its stage. The pairing does not require a query solely because the provider omitted the words due to. Actual conflicting documentation or missing stage may require clarification.
Acute respiratory failure and another acute condition
Section I.C.10.b permits acute or acute-and-chronic respiratory failure as principal when it meets the definition and the classification supports that selection. Chapter-specific sequencing directions, including obstetric, poisoning, HIV, and newborn rules, take precedence where applicable.
When respiratory failure and another acute condition coexist, the principal diagnosis depends on admission circumstances. Either may be selected under Section II.C only when they are equally responsible for admission and no chapter-specific rule directs sequencing. If that responsibility is unclear, query the provider. The treatment focus alone is not a universal tie-breaker, and respiratory failure that develops later does not automatically replace the admission diagnosis.
Acute-and-chronic respiratory failure also requires supported documentation of both components. Home oxygen use can prompt review but is not itself a provider diagnosis of chronic respiratory failure.
Drug events: distinguish proper use from improper use
Under Section I.C.19.e, the administration circumstances determine the drug-event pathway:
| Event | General assignment approach |
|---|---|
| Adverse effect of a correctly prescribed and properly administered drug | Nature of adverse effect first, then the appropriate drug adverse-effect code |
| Poisoning, such as overdose, wrong drug, or wrong route | Poisoning code first, then manifestations; identify the documented intent |
| Underdosing, taking less than prescribed or instructed | Underdosing code cannot be principal/first-listed; report the associated condition and known intent/circumstances as applicable |
| Toxic effect of a harmful nonmedicinal substance | Toxic-effect code first, followed by associated manifestations |
An elevated drug-effect laboratory result alone does not distinguish poisoning from an adverse effect. Review the prescription, actual administration, provider diagnosis, and causal documentation. For an actively treated, documented adverse effect of correctly administered anticoagulants, T45.515A identifies the drug adverse effect after the code for its nature. The code's descriptor is anticoagulants, not all antithrombotic drugs.
Use the required seventh character according to treatment phase: A for active treatment, D for routine healing/recovery after active treatment, and S for sequela when applicable. It is not determined simply by the first visit or the hospital's inpatient label. Check the FY2027 classification for complete codes, inherited instructions, and category-specific requirements.
An acute inpatient hospital discharge summary retains probable aspiration pneumonia after evaluation and treatment. No conflicting final diagnosis or applicable chapter-specific exception is present. The sputum culture did not identify a pathogen. How should the uncertain pneumonia be handled for diagnosis assignment?
Code the presenting symptoms instead because a disease diagnosis requires pathogen confirmation.
Require the provider to replace probable with confirmed before coding pneumonia.
Code the retained discharge diagnosis as if established under the hospital inpatient rule.
Use the outpatient uncertainty rule because a probable diagnosis has not been confirmed.
An inpatient has documented hypertension and stage 3b chronic kidney disease that meet reporting requirements. There is no heart disease, conflicting documentation, or statement that the conditions are unrelated. Which approach follows the hypertension/CKD convention?
Report I10 with N18.32 because the provider did not explicitly link the conditions.
Query for causal linkage before assigning any hypertensive CKD combination code.
Use category I13 with N18.32 because every hypertension/CKD case includes heart disease.
Report I12.9 with N18.32 to capture the presumed hypertension/CKD relationship and stage.
During active treatment, the provider documents gross hematuria caused by an adverse effect of warfarin. The drug was correctly prescribed and properly administered; no overdose, wrong drug, or wrong route occurred. Which general drug-event coding approach applies?
Assign the code for the nature of the adverse effect before T45.515A, adverse effect of anticoagulants, initial encounter.
Assign T45.511A, accidental poisoning by anticoagulants, before the code for the manifestation.
Assign T45.515A before the manifestation because every drug-event code must be first.
Assign an underdosing code before the manifestation because an adverse reaction means the prescribed dose was insufficient.
Sections you finish are checked off in the contents.